Oxime cross-linked biocompatible polymer hydrogels and methods of use thereof

Patent metadata

Field	Value
Publication number	US-10611880-B2
Application number	US-201515534269-A
Country	US
Kind code	B2
Filing date	Dec 9, 2015
Priority date	Dec 9, 2014
Publication date	Apr 7, 2020
Grant date	Apr 7, 2020

Abstract

Methods and hydrogels for preventing or reducing cellular adhesion and protein adsorption to a tissue (e.g. cardiac tissue) are disclosed. The hydrogels generally include at least two component polymers, a first polymer including an aminooxy group and a second polymer including a reactive oxo group, that are cross-linked by oxime bonds. The hydrogels are suitable for binding to and coating a tissue or cell. The hydrogels operate to reduce cellular adhesions and protein adsorption to the tissue or cell.

First claim

What is claimed is:

1. A method of protecting internal tissue of an individual with an in-situ post-surgical anti-adhesion barrier, comprising:
administering to an internal tissue adjacent to a surgical site of an individual in need thereof post-surgery an effective amount of a combination of a first polymer comprising an aminooxy group selected from a hydroxyl amine and an alkoxy amine, and a second polymer comprising a reactive oxo group,
wherein the first polymer and second polymer are mixed and react to form an oxime cross-linked biocompatible hydrogel proximate to the tissue,
wherein the oxime cross-linked biocompatible hydrogel forms a protective layer over the tissue to prevent post-surgical tissue adhesions,
wherein the hydrogel has a surface comprising a surface oxo group, and
wherein the surface oxo group reversibly binds a surface amine on the tissue to form an imine.

2. The method of claim 1 , wherein the tissue is cardiac tissue or another tissue found in the individual's thoracic cavity.

3. The method of claim 1 , wherein the oxime cross-linked biocompatible hydrogel is formed in about 5 minutes or less.

4. The method of claim 1 , wherein the first polymer and the second polymer are administered by spraying, dripping, or painting the first polymer and the second polymer directly onto the tissue.

5. The method of claim 1 , wherein the hydrogel is capable of adhering to the tissue for about two or more weeks.

6. The method of claim 1 , wherein the hydrogel reduces cellular adhesion and protein adsorption to the tissue.

7. The method of claim 1 , wherein the hydrogel swells to less than about 150% when hydrated.

8. A method of protecting internal tissue of an individual with an in-situ post-surgical anti-adhesion barrier, comprising:
administering to an internal tissue adjacent to a surgical site of an individual in need thereof post-surgery an effective amount of a combination of a first polymer comprising eight-armed aminooxy poly(ethylene glycol) and a second polymer comprising aldehyde poly(ethylene glycol),
wherein the first polymer and second polymer are mixed and react to form an oxime cross-linked biocompatible hydrogel proximate to the tissue,
wherein the oxime cross-linked biocompatible hydrogel forms a protective layer over the tissue to prevent post-surgical tissue adhesions,
wherein the hydrogel has a surface comprising a surface oxo group, and
wherein the surface oxo group reversibly binds a surface amine on the tissue to form an imine.

9. The method of claim 8 , wherein the tissue is cardiac tissue or another tissue found in the individual's thoracic cavity.

10. The method of claim 8 , wherein the oxime cross-linked biocompatible hydrogel is formed in about 5 minutes or less.

11. The method of claim 8 , wherein the first polymer and the second polymer are administered by spraying, dripping, or painting the first polymer and the second polymer directly onto the tissue.

12. The method of claim 8 , wherein the hydrogel is capable of adhering to the tissue for about two or more weeks.

13. The method of claim 8 , wherein the hydrogel reduces cellular adhesion and protein adsorption to the tissue.

14. The method of claim 8 , wherein the hydrogel swells to less than about 150% when hydrated.

15. The method of claim 8 , wherein the hydrogel comprises approximately between 25 and 200 mg/mL of the first polymer and the second polymer.

16. The method of claim 8 , wherein the hydrogel has a storage modulus of about less than 1 kPa.

17. The method of claim 8 , wherein the hydrogel swells to less than about 150% by volume when hydrated.

18. The method of claim 1 , wherein the reactive oxo group and the surface oxo group are ketones.

19. The method of claim 1 , wherein the reactive oxo group and the surface oxo group are aldehydes.

20. The method of claim 1 , wherein the aminooxy group is a hydroxyl amine.

21. The method of claim 1 , wherein the aminooxy group is an alkoxy amine.

22. The method of claim 1 , wherein the first polymer and the second polymer are each selected from the group consisting of poly(ethylene glycol), multi-arm poly(ethylene glycol), hyaluronic acid, alginate, dextran, carboxymethylcellulose, cellulose, poly(vinyl alcohol), or combinations thereof.

23. The method of claim 1 , wherein the first polymer comprises eight-armed aminooxy poly(ethylene glycol) and the second polymer comprises aldehyde poly(ethylene glycol).

24. The method of claim 1 , wherein the hydrogel comprises approximately between 25 and 200 mg/mL of the first polymer and the second polymer.

25. The method of claim 1 , wherein the hydrogel has a storage modulus of about less than 1 kPa.

26. The method of claim 1 , wherein the hydrogel swells to less than about 150% by volume when hydrated.

Assignees

• Univ California

Inventors

• Christman Karen
• Grover Gregory
• Madani Michael
• Fujita Masaki

Classifications

• C08J3/075

  Macromolecular gels · CPC title

• C08J2371/02

  Polyalkylene oxides · CPC title

• C08J2471/02

  Polyalkylene oxides · CPC title

• A61L24/0031

  Hydrogels or hydrocolloids · CPC title

• A61P41/00

  Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution · CPC title